These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16857751)

  • 1. Antidiabetic activity of a highly potent and selective nonpeptide somatostatin receptor subtype-2 agonist.
    Strowski MZ; Cashen DE; Birzin ET; Yang L; Singh V; Jacks TM; Nowak KW; Rohrer SP; Patchett AA; Smith RG; Schaeffer JM
    Endocrinology; 2006 Oct; 147(10):4664-73. PubMed ID: 16857751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice.
    Strowski MZ; Parmar RM; Blake AD; Schaeffer JM
    Endocrinology; 2000 Jan; 141(1):111-7. PubMed ID: 10614629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
    Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
    Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis.
    Strowski MZ; Kohler M; Chen HY; Trumbauer ME; Li Z; Szalkowski D; Gopal-Truter S; Fisher JK; Schaeffer JM; Blake AD; Zhang BB; Wilkinson HA
    Mol Endocrinol; 2003 Jan; 17(1):93-106. PubMed ID: 12511609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets.
    Singh V; Brendel MD; Zacharias S; Mergler S; Jahr H; Wiedenmann B; Bretzel RG; Plöckinger U; Strowski MZ
    J Clin Endocrinol Metab; 2007 Feb; 92(2):673-80. PubMed ID: 17105845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats.
    Cejvan K; Coy DH; Efendic S
    Diabetes; 2003 May; 52(5):1176-81. PubMed ID: 12716749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function and expression of somatostatin receptors of the endocrine pancreas.
    Strowski MZ; Blake AD
    Mol Cell Endocrinol; 2008 May; 286(1-2):169-79. PubMed ID: 18375050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Endogenous (Male) Rodent GLP-1 Secretion and Human Islet Insulin Secretion by Antagonism of Somatostatin Receptor 5.
    Farb TB; Adeva M; Beauchamp TJ; Cabrera O; Coates DA; Meredith TD; Droz BA; Efanov A; Ficorilli JV; Gackenheimer SL; Martinez-Grau MA; Molero V; Ruano G; Statnick MA; Suter TM; Syed SK; Toledo MA; Willard FS; Zhou X; Bokvist KB; Barrett DG
    Endocrinology; 2017 Nov; 158(11):3859-3873. PubMed ID: 28938487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The somatostatin receptor in human pancreatic β-cells.
    Braun M
    Vitam Horm; 2014; 95():165-93. PubMed ID: 24559918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function.
    Hauge-Evans AC; King AJ; Carmignac D; Richardson CC; Robinson IC; Low MJ; Christie MR; Persaud SJ; Jones PM
    Diabetes; 2009 Feb; 58(2):403-11. PubMed ID: 18984743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of somatostatin (SST) receptor type 5 (SSTR5) is associated with sexually dimorphic changes in the expression of SST and SST receptors in brain and pancreas.
    Ramírez JL; Grant M; Norman M; Wang XP; Moldovan S; de Mayo FJ; Brunicardi C; Kumar U
    Mol Cell Endocrinol; 2004 Jun; 221(1-2):105-19. PubMed ID: 15223137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound M & B 39890A [N-(3-imidazol-1-ylpropyl)- 2-(3-trifluoromethylbenezensulphonamido)-benzamide hydrochloride], a glucagon and insulin secretion inhibitor, improves insulin sensitivity in viable yellow obese-diabetic mice.
    Yen TT; Schmiegel KK; Gold G; Williams GD; Dininger NB; Broderick CL; Gill AM
    Arch Int Pharmacodyn Ther; 1991; 310():162-74. PubMed ID: 1772327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry.
    Rohrer SP; Birzin ET; Mosley RT; Berk SC; Hutchins SM; Shen DM; Xiong Y; Hayes EC; Parmar RM; Foor F; Mitra SW; Degrado SJ; Shu M; Klopp JM; Cai SJ; Blake A; Chan WW; Pasternak A; Yang L; Patchett AA; Smith RG; Chapman KT; Schaeffer JM
    Science; 1998 Oct; 282(5389):737-40. PubMed ID: 9784130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.
    Jin CH; Chae SY; Son S; Kim TH; Um KA; Youn YS; Lee S; Lee KC
    J Control Release; 2009 Feb; 133(3):172-7. PubMed ID: 18977255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues.
    Ludvigsen E; Stridsberg M; Taylor JE; Culler MD; Oberg K; Janson ET; Sandler S
    Regul Pept; 2007 Jan; 138(1):1-9. PubMed ID: 16935361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin inhibits insulin release via SSTR2 in hamster clonal beta-cells and pancreatic islets.
    Yao CY; Gill M; Martens CA; Coy DH; Hsu WH
    Regul Pept; 2005 Jul; 129(1-3):79-84. PubMed ID: 15927701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for islet somatostatin in mediating sympathetic regulation of glucagon secretion.
    Hauge-Evans AC; King AJ; Fairhall K; Persaud SJ; Jones PM
    Islets; 2010; 2(6):341-4. PubMed ID: 21099335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K
    Singh B; Khattab F; Chae H; Desmet L; Herrera PL; Gilon P
    Mol Metab; 2021 Nov; 53():101268. PubMed ID: 34118477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin and insulin mediate glucose-inhibited glucagon secretion in the pancreatic α-cell by lowering cAMP.
    Elliott AD; Ustione A; Piston DW
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E130-43. PubMed ID: 25406263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.